In this article we describe a new class of high-density optical microarrays based on molecularly imprinted microsphere sensors that directly incorporate specific recognition capabilities to detect enrofloxacin (ENRO), an antibiotic widely used for both human and veterinary applications. This approach involves the preparation of highly cross-linked polymer microspheres by thermal precipitation-polymerization in the 
Introduction
Biologically-inspired materials have attracted considerable interest over the last decade and have opened the door to new and important applications such as smart materials that can perform the same tasks as cells or organs.
1 Molecular imprinting allows the creation of synthetic materials that function with the selectivity and affinity of biological recognition elements such as antibodies or enzymes. 2 
Molecularly
Imprinted Polymers (MIPs) are articial materials containing molecularly engineered receptor sites for a large variety of target analytes. 3, 4 Such specic receptor sites are introduced when a target molecule (template) is mixed with a stoichiometric number of functional monomers and cross-linkers to form complementary cavities to the target molecule's structure, which becomes xed into the resulted polymer network during copolymerization. MIPs have been designed for the recognition of small molecules, such as toxins, for which it is difficult to obtain a corresponding biological receptor. In contrast to their natural counterparts, MIPs can be used efficiently under nonphysiological or harsh conditions, such as high temperature, low pH, or organic solvents.
MIPs have been used in a diverse number of applications, such as solid-phase extraction, chromatographic sorbents, polymeric catalysts and sensory materials. 3, 5 The utility of MIPs is boosted by their versatility and ease of preparation in a plurality of formats such as gels, membranes, laments or nano/microspheres. 6, 7 For example, MIPs have been proven to be excellent materials for selective solid-phase extraction of uoroquinolone antimicrobials (FQs). 8 These drugs are widely prescribed to both humans and food-producing animals and their "uncontrolled" use, or disposal, may give rise to the presence of FQ residues in foods and also may lead to resistance that creates challenges for health care systems.
9,10 Conventional enzyme-linked immunosorbent assays and microbial inhibition tests are the methods of choice for bulk screening of these antimicrobials; 11, 12 however, they have inherent limitations as they employ expensive bioreagents, are time-consuming, and require sophisticated laboratory infrastructure and technical expertise.
The direct optical detection of FQs requires UV excitation (l exc 280, 320 nm) and their native uorescence (ca. l exc 400-420 nm) is inuenced by interferences caused by both autouorescence of the samples and light scattering off the polymer particles. In order to overcome these limitations, we previously reported a proof of concept where two immuno-like detection systems for FQs combining MIPs and either europium-amplied luminescent 13 or Förster resonance energy transfer (FRET)-based photochemical sensing.
14 Although both approaches worked, the reported LODs and the design scheme required improvements in order to be easily adaptable to cheap and portable systems.
15
This paper describes a new MIP-based sensing platform that combines MIP microspheres with bead-based microarrays. This combination benets from the advantages of tailor-made biomimetic materials in addition to a well-established array technology. Our sensing microspheres were prepared by thermal precipitation-polymerization, which is the mainstay method for obtaining polymeric microspheres with extremely uniform sizes and homogeneous binding site distribution.
16
Moreover, microspheres feature a high surface-to-volume ratio, which results in better binding kinetics, ease of manipulation, and the ability to multiplex by encoding the microspheres.
17
Additionally, to illustrate the multiplexing abilities of the assay, we used both MIP beads and NIP beads (negative control) so we could account for non-specic binding and background.
The platform described in this article has its roots in the use of optical ber bundles and encoded microsphere-based arrays that Walt and colleagues have pioneered as powerful tools for many practical uorescent biosensing applications.
18-21 The optical ber bundles are chemically etched with an acid solution 22 to create a planar array of microwells where uorescently encoded MIP and NIP bead types are pooled to form a randomly ordered but addressable high density array. 23 The bead-based competition assay is then performed by incubating the array in a sample containing both the antibiotic ENRO and a uorescent analogue of the antibiotic (BODIFLOXACIN), which competes for active sites within the imprinted microspheres. The encoding, assay protocols and data handling were optimized to allow multiplexing while preserving both sensitivity and specicity. Fiber-optic MIP microsphere-based arrays have been successfully applied to the analysis of ENRO in the serum of a healthy sheep aer intravenous administration of the drug and the results have been fully validated by HPLC-FLD.
Experimental

Materials and instrumentation
Optical ber bundles containing approximately 50 000 individual optical bers (with diameters of 3.1 mm) were purchased from SCHOTT North America, Inc. N- The pH of all buffered solutions was adjusted with a GLP 22 pH meter from Crison (Barcelona, Spain). The semi-preparative HPLC system consisted of an HP1200 LC from Agilent Technologies (Palo Alto, CA) equipped with a solvent delivery quaternary pump, an autosampler, diode array detector (DAD), and an analytical scale fraction collector. Chromatographic purication of the new FQ was carried out on a ZORBAX Eclipse XDB-C18 semipreparative column (250 mm Â 9.4 mm, 5 mm) from Agilent Technologies (Palo Alto, CA). Chromatographic analysis of the antibiotics was performed with a HP1100 LC from Agilent Technologies (Palo Alto, CA) equipped with a quaternary pump, online degasser, autosampler, automatic injector, and a column thermostat. A uorescence detector (FLD) system was coupled online with the DAD system. Chromatographic separation was performed on an Aqua C18 analytical column (polar endcapped; 250 mm Â 4.6 mm, 5 mm) from Phenomenex (Torrance, CA). Scanning electron microscopy (SEM) measurements were performed with a JEOL JSM-6330F eld-emission scanning electron microscope at an acceleration voltage of 5 kV. The samples were coated with a thin gold lm before analysis. Optical ber bundles were imaged with an Olympus BX51 epi-uorescence microscope (Olympus America Inc. Center Valley, PA). The microscope is equipped with a color charge-coupled device (CCD) camera (Innity 3, Lumenera Corporation), a 100 W halogen lamp (operating at 6 V to acquire bright eld images and 12 V for uorescence images), and three uorescence lter sets for C30 (excitation 405/10, dichroic Q414LP, emission 425LP), BOD-IPY® TR Cadaverine (excitation 550/10, dichroic T600LPXR, emission 590LP) and [Ru(dip) 3 ]Cl 2 (excitation 470/10, dichroic 490DCXR, emission 500LP).
Synthesis and encoding of microspheres
Molecularly imprinted microspheres selective to ENRO were prepared following a precipitation-polymerization approach, 16 as previously reported. 8 Briey, a mixture of template molecule, ENRO (362 mg, 1 mmol), functional monomer, MAA (350 mL, 4 mmol), and diluent monomer, HEMA (496 mL, 4 mmol) were dissolved in 30 mL of MeCN. The radical initiator, ABDV (25 mg, 0.1 mmol) was dissolved in EDMA (960 mL, 5 mmol) and DVB (1300 mL, 5 mmol). This mixture was then added to the prior solution to yield the pre-polymerization mixture. Prior to polymerization, the mixture was homogenized in an ultrasonic bath for 5 min, transferred to a borosilicate glass reactor, and gently purged with argon for 10 min. A stir blade, coupled to a rotor head, maintained slow stirring (34 rpm were prepared in MeCN, and a drop of 1 mL of the suspension was deposited onto the etched distal end of the ber. The ber was kept in the dark for 5 min to allow complete evaporation of the solvent and appropriate incorporation of the microspheres into the microwells. The process was repeated 10 times to increase microspheres loading efficiency and achieve approximately 1000 microspheres over the entire measuring area of one ber-optic microarray. Excess microspheres, those not loaded into the microwells, were removed using a cotton swab. The workow of the assay protocol is depicted in Fig. 1 .
Assay protocol
ENRO quantication was based on a competitive assay where the target analyte competes with the labeled ENRO (BODI-FLOXACIN) to bind to specic binding sites on the MIP microspheres. The distal end of the ber that holds the microspheres was incubated in 1 mL of (50 : 50, v/v) MeCN : HEPES 25 mM pH 7.5, containing a constant amount of BODIFLOXACIN (250 nM) and increasing amounts of ENRO (0-1000 mM) while shaking for 1 h at 70 rpm. Aer incubation, the ber was washed with 1 mL of wash buffer ((50 : 50, v/v) MeCN : HEPES (25 mM, NaCl 138 mM, KCl 2.7 mM pH 7.5)) while shaking for 5 min at 70 rpm. The washing step was repeated three times. In the last step, the ber was dipped in 1 mL of MeCN, shaken for 5 min at 70 rpm, and then dried and mounted onto a specially-designed microscope platform for measuring ber-optic microarrays. The workow of the assay protocol is depicted in Fig. 2 .
Image capturing and data analysis
The ber-optic microarray was placed vertically with respect to the microscope objective in a home-built ber holder. Images were acquired with an epi-uorescence microscope (Olympus BX51) as described before. The bers were imaged with 20Â magnication for different exposure times ( For data analysis, uorescence micrographs were set as RGB images and deconvoluted in their respective channels. Green and blue channels were discarded and the analysis was performed in the red channel. A threshold for intensities (9-255 a.u.) was applied and the microspheres were analyzed by displaying the measurements inside their size range of 30-130 pixel 2 with a circularity of 0.7-1.0. The tri-mean criterion (see ESI †) was employed instead of conventional mean statistics to avoid outliers, which gives more importance to the center of the population than to external points and thus provides a more robust analysis.
Microarray fabrication
The experimental data obtained for calibration plots were tted to eqn (1), which represents a 4-parameter logistic (4 PL) regression model. 
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Normalized signal ðY Þ ¼
where B max is the asymptotic maximum (maximum emission of BODIFLOXACIN in the absence of ENRO), B min is the asymptotic minimum, b is the slope of the curve, and IC 50 is the concentration of ENRO at the inection point (where a decrease of 50% for B max was found). Results obtained were plotted as a function of B (uorescence signal of BODIFLOXACIN in the presence of ENRO) with respect to B 0 (uorescence signal of BODIFLOXACIN in the absence of ENRO) normalized to the value of the signal when the curve reached saturation at high concentrations of ENRO (B N , dened as the value of B minus 0.02 times the same B). Normalization follows eqn (2):
Sheep serum sample collection and preparation ENRO 10% (p/v) (Baytril® 10%, Bayer, Germany) was administered to a healthy female lactating sheep (ca. 70 kg) in a dose of 5 mg kg À1 via injection in the right jugular. Blood samples (3 mL) were collected in the le jugular at 0 and 5 min. aer drug administration. 27 Blood samples were centrifuged at 3400 rpm for 15 min to obtain serum, which was stored at À20 C. For ENRO analysis, samples were treated as follows:
100 mL of serum was mixed with 280 mL of MeCN. The mixture was then centrifuged at 13 000 rpm for 15 min. 285 mL of the supernatant was mixed with 15 mL of 7.5 mM BODIFLOXACIN in MeCN and 150 mL of HEPES (37.5 mM, pH 7.5). For calibrations in serum samples, 100 mL of the serum extracted 0 min aer drug administration was mixed with 280 mL of various concentrations of ENRO in MeCN ranging from 0 to 500 mM. Aer centrifugation (13 000 rpm, 15 min), 285 mL aliquots were mixed with 15 mL of 7.5 mM BODIFLOXACIN in MeCN and 150 mL of HEPES (37.5 mM, pH 7.5).
Results and discussion
Bead based optical ber microarrays utilize uorescently encoded microparticles, further conjugated with specic biorecognition elements (antibodies, antigens, enzyme substrates, oligonucleotides, etc.) for the simultaneous detection of multiple analytes in a sample. The application of this strategy in combination with imprinted polymers has not been explored so far, although these biomimetics offer an alternative to surmount the problems associated with the use of biological recognition elements such as the cost of in vivo production of some biomolecules and the social concern about experiments with animals. In contrast to biologically-derived recognition elements, MIPs are thermally and chemically stable and have long-term storage stability at room temperature.
4,6
The preparation of MIP-based microarrays requires imprinted spherical beads with the right size to be deposited in the etched ber optic microwells. In addition, the polymers should be encoded with uorescent dyes to enable the identication of each bead type, without compromising the selective recognition properties of the resulting material. Finally, the optical properties of the MIP should change in response to the presence of the target analytes. As a proof of concept, this paper describes the development of microarrays prepared with ENRO-selective MIPs and their corresponding NIPs for preparing multiplexed MIP-based ber optic arrays.
MIP/NIP beads synthesis, encoding and image capturing
The polymers were prepared by precipitation polymerization using ENRO as template, MAA as functional monomer, HEMA as diluent monomer and a mixture of EDMA and DVB (p-DVB and m-DVB isomer mixture) as cross-linkers (molar ratio, 1 : 4 : 4 : 5 : 5). The synthesis was optimized to obtain spherical beads with a diameter of 3.22 AE 0.03 mm, as deduced from DLS measurements. As reported in the literature, the core of beads prepared with a mixture of MAA and DVB (p-DVB and m-DVB isomers) monomers is richer in p-DVB. Therefore, in principle, such particles could be encoded with hydrophobic dyes without affecting the recognition properties of the most external layers, where methacrylic monomers and m-DVB units tend to polymerize randomly.
28
The MIP and NIP beads were encoded with C30 or [Ru(dip) 3 ] Cl 2 , respectively by swelling the beads in a THF solution containing the dyes. 29 Aer incubation, cold methanol was used to deswell the microspheres and physically trap the encoding uorophores in the polymer matrix. Following this protocol, NIP and MIP each contained a different label and could be easily identied demonstrating, for the rst time, the potential of this strategy for the development of encoded MIP-based multiplexed assays.
Using the conditions depicted in Table S2 , † both encoding dyes can be monitored by exciting microspheres at 405 nm. Fig. 3a shows the emission of red light (due to NIP microspheres, encoded with [Ru(dip) 3 ]Cl 2 ) and blue light (due to MIP microspheres, encoded with coumarin-30). Only the ruthenium complex emits when the sample is excited at 470 nm, (Fig. 3b) , verifying the location of NIP microspheres in the previous image. Applying the algorithm described by Nie et al. 30 (details in ESI †) two different populations were distinguished (Fig. 3c) , demonstrating the capability of multiplexing.
The reproducibility of the encoding protocol and the recognition capabilities of both the MIPs and NIPs were evaluated by detecting 250 nM BODIFLOXICIN in the presence and absence of ENRO using different microspheres batches. The results show no statistical variance between different batches prepared by different researchers during the last ve years and highlight the excellent long-term stability of these materials.
The encoded MIP and NIP beads were subjected to the assay conditions (buffers, hydro-organic solvent mixtures, incubation times, temperatures), in the absence of the target molecule, to determine if there was any uorophore leakage. No detectable amounts of either C30 or Ru(dip) 3 were detected in the supernatants by HPLC-FLD, at the detection limit of the technique. These experiments were carried out for different bead batches and over a period of, at least, one year.
Synthesis and characterization of BODIFLOXACIN
Several approaches have been described for the functionalization of the piperazine ring at position C-7 of the FQs.
14 However, as reported previously 8 selective interactions between the binding groups in the MIP and ENRO involves this moiety. Therefore, although the reactivity is remarkably lower, 31 the antibiotic was labeled with BODIPY® TR Cadaverine by reaction with the carboxyl group at position 3 of ENRO, as described in the ESI. †
32-34
The absorption and emission spectra of the uorescent analogue of ENRO, namely BODIFLOXACIN, are shown in Fig. 4 . The compound has an absorption maximum at 588 nm,
À1 cm À1 , and shows a uorescence emission peak centered at 624 nm, in MeCN. The uorescence quantum yield (F em ) was 0.73 AE 0.02. The selection of a BODIPY derivative for antibiotic labeling, instead of other commonly applied dansyl or cyanine dyes, 14, 35 was based on the high photostability and pH-insensibility of this uorophore, which are two important properties for epi-uorescence studies in competitive assays.
Assay optimization and array characterization
Several parameters, including the incubation solvent, the amount of polymer and the concentration of BODIFLOXACIN have been evaluated to select the optimum conditions for the competitive assay. Aer incubation, the amount of ENRO and BODIFLOXACIN not retained by the MIP/NIP beads was monitored by HPLC-FLD (see ESI † for details). The optimized measurement conditions are shown in Table 1 .
The binding kinetics of BODIFLOXACIN to the MIP microspheres in the presence and absence of a constant concentration of ENRO are depicted in Fig. 5 . Incubations were carried out aer depositing the microspheres onto the ber-optic microwells. The signal response leveled off aer 1 h incubation, which compares favorably with the analysis time of immunoassays reported in the literature for FQ detection 36 and was selected for all subsequent competitive assays. Competitive calibration curves were prepared by incubation of a freshly assembled MIP/NIP microarray in 1 mL of ENRO standards, with concentrations ranging from 0 to 1000 mM, prepared in 50 : 50 (v/v) MeCN : HEPES (25 mM, pH 7.5). As shown in Fig. 6 , BODIFLOXACIN competes efficiently with ENRO for the selective binding sites in the MIP, as the labeled analogue was displaced from the imprinted beads in the presence of increasing concentrations of the antibiotic. The experimental data have been tted to eqn (1) (n ¼ 14, r 2 ¼ 0.98, blue points). The IC 50 value is 3.5 mM and the LOD is 40 nM, calculated as the ENRO concentration for which BODIFLOXACIN binding to MIP was inhibited by 10%. 37 The dynamic range (DR), i.e., the concentration range of ENRO that produces an inhibition of the signal between 20 and 80%, is between 290 nM and 21.5 mM. Furthermore, no competition was observed with the encoded NIP microspheres (n ¼ 9, orange points), that were interrogated simultaneously with the MIP beads. This result conrms that nonspecic interactions are completely suppressed in the optimized assay conditions; therefore, it can be concluded that BODIFLOXACIN competes with ENRO for the specic binding sites in the MIP.
There are only a few examples in the literature of MIP-based optical methods for FQ detection, with none of the measuring schemes being compatible with a multiplexing approach, as described in this work. Moreover, except for the work of XuanAnh Ton et al. 38 that reported the analysis of FQs using a solution of MIP nanoparticles and direct uorescence polarization measurements, the detection limit achieved with the microarray is lower than for other competitive uoroimmuno-like assays, using either structurally related or unrelated labeled analogues.
39,40
The inter-day assay reproducibility was evaluated in terms of the relative standard deviation (RSD in %) for a xed amount of BODIFLOXACIN measured in ve independent tests (B 0 ) performed during different months and at different temperatures (17-28 C) . The average RSD ranged from 3% to 8%. These values are comparable, or even better, than those reported in other studies using microsphere-based platforms with on a variety of bio-recognition elements, assay formats, and target analytes. 41 In addition, improved reproducibility was observed when compared to other immunoassays for the detection of FQs described in the literature. 42 
Cross reactivity
The potential cross-reactivity between MIP microspheres and other interfering substances was also evaluated by testing the microarrays with single antimicrobial standards. The responses caused by cross-reactivity, expressed as % Inhibition of BODI-FLOXACIN, were less than 1% (see Fig. 7 ) for NORF, DANO, FLUME, PGP, and DOXY, while the inhibition obtained for CIPRO was 8%. Responses from NIP microspheres were negligible. These results conrm the excellent selectivity of the MIP based microarray for the template molecule and this lack of cross-reactivity represents a major improvement over many commercially available uoroquinolone assays. 
Sheep serum sample
The optimized ber-optic MIP array has been applied to the analysis of ENRO in sheep serum samples. In order to investigate the presence of matrix effects, sheep's serum samples not treated with antibiotics were diluted with water and spiked with increasing concentrations of ENRO, ranging from 0 to 500 mM and analysed using the microarray. Fig. 8 shows the comparison of the dose-calibration curves obtained in serum and in water. The results suggest that matrix effects for a 6-fold dilution of serum were negligible. No statistically signicant differences were observed. In fact, the calibration plots overlap in water IC 50 ¼ 3.5 mM (AE0.8 mM) compared to serum IC 50 ¼ 3.4 mM (AE0.6 mM), as well as in the condence intervals of 95% and 98%, respectively.
Three samples of sheep serum were collected 5 min aer drug administration, treated, and then measured using the array platform and HPLC-FLD for validation purposes. The results obtained using the MIP assay were 20 mM (AE2 mM) of ENRO and 19.9 mM (AE0.2 mM) of ENRO using the HPLC-FLD system. These results conrmed that no statistical differences in the variances and averages values at any condence level were observed demonstrating the excellent performance of the ber-optic array using MIP microspheres for ENRO analysis in serum samples.
Conclusions
In this paper, we described a new ber-optic microarray based on MIP microspheres for the antibiotic ENRO. Exhaustive optimizations have been performed for all aspects of the assay including imprinted and non-imprinted microspheres synthesis and encoding, synthesis and characterization of a novel uorescently-labeled ENRO, image processing, data analysis, and applications to real samples. Our platform, based on the combination of a microarray of optical ber bundles with MIP microspheres and epi-uorescence imaging detection, has not only shown the ability to improve upon the LODs previously described in the literature for this type of assay, but has also demonstrated its potential in multiplexed analysis. The basic assay design is exible and should be applicable with other MIP microspheres selective to other target molecules. In addition, the platform can be applied to the analysis of real serum samples, can be used in the presence of organic solvents, and is both more reproducible and faster than other similar bioassays reported previously.
